Imbio LLC entered the industry of Commercial Medical Research in 2012 and has grown to employ 1 to 4 people, generating an annual revenue of $50.000 to $99.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Danny Cunagin by calling (612) 520-7361 during business hours. You can also write to the business’ Single Location at 227 Colfax Avenue North # 150, Minneapolis, Minnesota MN 55405. You can also visit the company’s website at imbio.com. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Imbio LLC |
Representative: | Danny Cunagin |
Place of Business: | 227 Colfax Avenue North # 150, Minneapolis, MN 55405 |
Contact Number: | (612) 520-7361 |
Website: | imbio.com |
Type of Service: | Commercial Medical Research |
SIC Number: | 8731 |
NAICS Number: | 541712 |
Locality: | Single Location |
Market Type: | B2B (Business to Business) |
Began: | 2012 |
Income/Year: | $50.000 to $99.999 |
Laborers: | 1 to 4 |
Share This Company: |
Imbio LLC is a company operating from Hennepin, Minnesota providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2012 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Imbio LLC has gone to report making $50.000 to $99.999 per annum on its journey towards growth. This company invites you to contact its representative Danny Cunagin at (612) 520-7361 for related queries, or to locate its Single Location using the coordinates 44.978569,-93.291738.
The Single Location can also be found at the street address 227 Colfax Avenue North # 150 in Minneapolis, Minnesota 55405 and can be engaged online through the company website at imbio.com, the company Twitter , and Facebook page .